The U.S. Food and Drug Administration has downgraded the classification of full-field digital mammography devices from high risk to medium risk, making it easier for companies to bring the technology to market, the agency announced today.
FDA eases rules on digital mammography devices
Nov 3, 2010
Latest in Breast
ACR releases updated BI-RADS manual
December 1, 2025
Ikonopedia adds CEM to its offerings
November 30, 2025
FDA signs off on GE HealthCare’s 3D mammography software
November 26, 2025















